11/11
11:18 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
10/18
08:26 am
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/18
08:26 am
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/1
01:05 pm
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/1
01:05 pm
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/1
10:35 am
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/1
10:35 am
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/1
10:24 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
10/1
10:24 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
10/1
09:12 am
igms
Rating for IGMS
High
Report
Rating for IGMS
10/1
07:57 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $9.00 price target on the stock, down previously from $12.00.
High
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $9.00 price target on the stock, down previously from $12.00.